drugset
drugset / Trial / NCT06684951

Effects of Intrauterine Flushing With Human Chorionic Gonadotropin on ICSI Outcome

NCT06684951 ↗

Phase 4 Completed 90 enrolled Omayma Ismail Khalaf
RandomizedParallel-groupDouble-blindTreatment

Summary

a number of infertile women who were prepared for ICSI and immediately post ova pick up intrauterine flushing with human chorionic gonadotropin was done to study the effect of this drug on ICSI outcome and ultrasound parameter.

Timeline

Start
2022-10-23
Primary completion
2024-01-23
Completion
2024-04-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator human chorionic gonadotropin Protein / enzyme biologic 500 iu Other
Comparator human chorionic gonadotropin Protein / enzyme biologic 700 iu Other

Indications

female infertility